Facai Zhang

669 total citations
27 papers, 444 citations indexed

About

Facai Zhang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Facai Zhang has authored 27 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Facai Zhang's work include Ferroptosis and cancer prognosis (10 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Epigenetics and DNA Methylation (4 papers). Facai Zhang is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Epigenetics and DNA Methylation (4 papers). Facai Zhang collaborates with scholars based in China. Facai Zhang's co-authors include Dechao Feng, Dengxiong Li, Xu Shi, Qiao Xiong, Lu Yang, Qiang Wei, Wuran Wei, Jun Shen, Li Liu and Jiang Gu and has published in prestigious journals such as The EMBO Journal, Frontiers in Immunology and Life Sciences.

In The Last Decade

Facai Zhang

26 papers receiving 444 citations

Peers

Facai Zhang

PRM

ONCOL

SURGE

Kaijing Wang China

Feng Cao China

Daochun Luo Canada

Matthew Teater United States

W-T Chen Taiwan

Xin Lin China

Yunong Fu China

Kaitlyn A. Sun United States

Caixia Wang China

Yuki Oda Japan

Kaijing Wang China

Facai Zhang

177 ×0.8

117 ×0.6

134 ×0.8

PRM

87 ×1.1

ONCOL

61 ×1.0

SURGE

Citations per year, relative to Facai Zhang Facai Zhang (= 1×) peers Kaijing Wang

Countries citing papers authored by Facai Zhang

Since Specialization

Citations

This map shows the geographic impact of Facai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Facai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Facai Zhang more than expected).

Fields of papers citing papers by Facai Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Facai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Facai Zhang. The network helps show where Facai Zhang may publish in the future.

Co-authorship network of co-authors of Facai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Facai Zhang. A scholar is included among the top collaborators of Facai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Facai Zhang. Facai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yifan, Changfang Zhou, Facai Zhang, et al.. (2025). Integrated identification of immune-related therapeutic targets for interstitial cystitis via multi-algorithm machine learning: transcriptomic profiling and in vivo experimental validation. Frontiers in Immunology. 16. 1636855–1636855.

Li, Xiangrong, Facai Zhang, Ying Kong, et al.. (2024). Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis. The EMBO Journal. 43(21). 4954–4983. 17 indexed citations

Wang, Xiaoming, Yunjin Bai, Facai Zhang, et al.. (2023). Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation. Frontiers in Immunology. 14. 955949–955949. 16 indexed citations

Shen, Zhiyong, Dong Xue, Kun Wang, et al.. (2022). Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway. BMC Urology. 22(1). 79–79. 15 indexed citations

Feng, Dechao, Xu Shi, Facai Zhang, et al.. (2022). Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy. Frontiers in Immunology. 13. 839362–839362. 23 indexed citations

Feng, Dechao, Xu Shi, Qiao Xiong, et al.. (2022). A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. Frontiers in Cell and Developmental Biology. 10. 803766–803766. 23 indexed citations

Feng, Dechao, Xu Shi, Qiao Xiong, et al.. (2022). A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer. Frontiers in Oncology. 11. 805571–805571. 11 indexed citations

Feng, Dechao, et al.. (2022). The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 790381–790381. 6 indexed citations

Wu, Ruicheng, Dengxiong Li, Facai Zhang, et al.. (2022). Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor. Frontiers in Surgery. 9. 907485–907485. 9 indexed citations

10.

Li, Dengxiong, Xiaoming Wang, Dechao Feng, et al.. (2022). Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for Non-Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 12. 937638–937638. 6 indexed citations

11.

Hu, Huan, et al.. (2022). Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis. Frontiers in Immunology. 13. 860676–860676. 17 indexed citations

12.

Feng, Dechao, Dengxiong Li, Xu Shi, et al.. (2022). A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer. Journal of Translational Medicine. 20(1). 252–252. 28 indexed citations

13.

Feng, Dechao, Facai Zhang, Dengxiong Li, et al.. (2022). Developing an immune‐related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer. Immunology. 166(2). 197–209. 16 indexed citations

14.

Li, Dengxiong, Qingxin Yu, Facai Zhang, et al.. (2022). Systemic Immune-inflammation Index (SII) During Induction has Higher Predictive Value Than Preoperative SII in Non-muscle-invasive Bladder Cancer Patients Receiving Intravesical Bacillus Calmette -Guerin. Clinical Genitourinary Cancer. 21(3). e145–e152. 16 indexed citations

15.

Feng, Dechao, Facai Zhang, Ling Liu, et al.. (2021). SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma. International Journal of General Medicine. Volume 14. 8591–8602. 8 indexed citations

16.

Zhang, Facai, et al.. (2021). Identification and Validation of ATF3 Serving as a Potential Biomarker and Correlating With Pharmacotherapy Response and Immune Infiltration Characteristics in Rheumatoid Arthritis. Frontiers in Molecular Biosciences. 8. 761841–761841. 7 indexed citations

17.

Zhang, Facai, Dechao Feng, Xiaoming Wang, et al.. (2021). An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer. Frontiers in Molecular Biosciences. 8. 780329–780329. 8 indexed citations

18.

Wang, Jiahao, Yunjin Bai, Shan Yin, et al.. (2020). Circadian clock gene BMAL1 reduces urinary calcium oxalate stones formation by regulating NRF2/HO-1 pathway. Life Sciences. 265. 118853–118853. 20 indexed citations

19.

Wang, Xiaoming, Yunjin Bai, Facai Zhang, et al.. (2020). <p>Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder</p>. OncoTargets and Therapy. Volume 13. 9543–9558. 28 indexed citations

20.

Li, Dengxiong, Yubo Yang, Dechao Feng, et al.. (2020). <p>Clinical Characteristics and Prognosis of Rare Histological Variants of Bladder Cancer: A Single-Center Retrospective Study from China</p>. Cancer Management and Research. Volume 12. 9635–9641. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact